- This event has passed.
Bringing University Innovations to Market
January 20, 2021 @ 3:30 pm - 6:00 pm EST
Recordings
Full Length
For those who want to learn how to move innovative technologies from the university to commercial development for potentially game changing medical products.
When:
Jan 20, 2021
3:30 – 6:00 PM (EDT)
Where:
Online
Massachusetts
United States
Contact:
William Munger
wmunger@mdgboston.org
617-620-4161
Bringing University Innovations to Market
Learn How Artificial Intelligence (AI), Machine Learning (ML), and Robotics Are Rapidly Advancing The Medical Device Industry
Advancing technologies for unmet medical needs – hear and meet both experienced and rising entrepreneurs on:
- Incubators & Accelerators
- Role of industry partnerships & funding
- Developing & managing R&D portfolios
- Specific products & more
Wed, Jan 20, 3:30 – 6:00pm (EST)
3:30 – 4:00 General Networking
4:00 – 5:30 Panelist presentations
5:30 – 6:00 More Networking and ‘Meet the Speakers’
Forum Fees
$0
Overview
For those who want to learn how to move innovative technologies from the university to commercial development for potentially game changing medical products
Academic research is an important driver of biotech innovation and startup formation, and until recently a lonely endeavor with little to no guidance available to entrepreneurial researchers.
The last 5-10 years have seen great strides made in the Boston area with the development of multiple innovation and translation programs for graduates and fellows as well as the formation of incubators and accelerators within and in proximity to leading universities.
This session will provide a well-rounded overview of the process of forming a company out of academic research, the academic support system available at our top institutions and the role of external industry partnerships and funding.
The assembled panel includes both junior and senior academic entrepreneurs, a director from one of Harvard’s innovation support ecosystems and a Fortune 500 executive leading a local team in building, advancing, and managing the company’s External R&D portfolio of co-investments across pharmaceutical, consumer health and medical devices.
PANELISTS
Natalie Artzi, PhD
Assistant Professor at Brigham and Women’s Hospital & Founder of Biodevek
Biodevek arose from Natalie’s postdoctoral research & seeks to transform the field of surgical & topical adhesive materials.
Next generation adhesives: protecting sutures from leakage after surgery
Nicole Black, PhD
Gliklich Healthcare Innovation Post-doctoral Research Fellow, MGH/Wyss, & Cofounder, Beacon Bio.
Originating from her postdoctoral research, Beacon Bio seeks to design and produce PhonoGraft, a novel 3D-printed device from a biodegradable ink, which repairs damaged eardrums and passively enhances sound conduction.
Innovative repair for severe hearing loss inspired by victims of the Boston Marathon Bombings in 2013
Angelika Fretzen, PhD, MBA
Technology Translation Director, Wyss Institute, Harvard
A product development executive with over 20 years of experience in academia and biotech, Angelika joined the Wyss Institute in 2019 with product & business development responsibilities. She is currently transitioning into the role of the Institute’s Chief Operating Officer.
A leading academic executive who makes technology transfer happen
Michal Preminger, PhD, MBA
Head, Johnson & Johnson Innovation, East North America
A former Executive Director of Harvard University’s Office of Technology Development she now leads J&J’s Innovation Center team in building, advancing, and managing the External R&D portfolio of co-investments across pharmaceutical, consumer health and medical devices.
A key industry executive who identifies & promotes innovation
CO-CHAMPIONS
Rami Tzafriri, PhD
Director of Research and Innovation at CBSET
David Parillo, MBA
Senior Account Executive at CBSET
Karen Kelley, MA
Assistant Director, Co-op Bioengineering and Chemical Engineering Northeastern University
MODERATOR
Peter Markham, MS
Cofounder, President & CEO, CBSET
Peter founded CBSET in 2006 and has 25 years of management and regulatory experience in GLP contract research helping Fortune 500 and academic entrepreneurs bring drug and device based therapies to market.